Abstract
It has been proposed that introducing tyrosine residues into human hemoglobin (e.g. βPhe41Tyr) may be able to reduce the toxicity of the ferryl heme species in extracellular hemoglobin-based oxygen carriers (HBOC) by facilitating long-range electron transfer from endogenous and exogenous antioxidants. Surface-exposed residues lying close to the solvent exposed heme edge may be good candidates for mutations. We therefore studied the properties of the βLys66Tyr mutation. Hydrogen peroxide (H2O2) was added to generate the ferryl protein. The ferryl state in βLys66Tyr was more rapidly reduced to ferric (met) by ascorbate than recombinant wild type (rwt) or βPhe41Tyr. However, βLys66Tyr suffered more heme and globin damage following H2O2 addition as measured by UV/visible spectroscopy and HPLC analysis. βLys66Tyr differed notably from the rwt protein in other ways. In the ferrous state the βLys66Tyr forms oxy, CO, and NO bound heme complexes similar to rwt. However, the kinetics of CO binding to the mutant was faster than rwt, suggesting a more open heme crevice. In the ferric (met) form the typical met Hb acid-alkaline transition (H2O to −OH) appeared absent in the mutant protein. A biphasicity of cyanide binding was also evident. Expression in E. coli of the βLys66Tyr mutant was lower than the rwt protein, and purification included significant protein heterogeneity. Whilst, βLys66Tyr and rwt autoxidised (oxy to met) at similar rates, the oxygen p50 for βLys66Tyr was very low. Therefore, despite the apparent introduction of a new electron transfer pathway in the βLys66Tyr mutant, the heterogeneity, and susceptibility to oxidative damage argue against this mutant as a suitable starting material for a HBOC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alayash AI (2014) Blood substitutes: why haven’t we been more successful? Trends Biotechnol 32:177–185
Reeder BJ, Grey M, Silaghi-Dumitrescu RL et al (2008) Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering non toxic blood substitutes. J Biol Chem 283:30780–30787
Reeder BJ, Svistunenko DA, Cooper CE et al (2012) Engineering tyrosine-based electron flow pathways in proteins: the case of aplysia myoglobin. J Am Chem Soc 134:7741–7749
Portoro I, Kocsis L, Herman P et al (2008) Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity and renal filtration. Biochim Biophys Acta 1784:1402–1409
Acknowledgments
We acknowledge financial support from BBSRC (BB/L004232/1).
Disclosure
Cooper and Reeder have patents relating to the introduction of tyrosine residues into recombinant hemoglobin as a component of a blood substitute
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media, New York
About this paper
Cite this paper
Silkstone, R.S. et al. (2016). The βLys66Tyr Variant of Human Hemoglobin as a Component of a Blood Substitute. In: Elwell, C.E., Leung, T.S., Harrison, D.K. (eds) Oxygen Transport to Tissue XXXVII. Advances in Experimental Medicine and Biology, vol 876. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3023-4_57
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3023-4_57
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3022-7
Online ISBN: 978-1-4939-3023-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)